Study on the control of a novel coronavirus (2019nCoV)

  • Funded by Japan Agency for Medical Research and Development (AMED)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2019
    2019
  • Funder

    Japan Agency for Medical Research and Development (AMED)
  • Principle Investigator

    Pending
  • Research Location

    Japan, Western Pacific
  • Lead Research Institution

    Institute of Medical Science, The University of Tokyo
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Disease models

  • Special Interest Tags

    Gender

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The research group will 1) develop animal models for 2019-nCoV, 2) verify the usefulness of human monoclonal antibody established from 2019-nCoV-infected patients, and 3) prepare a gene vaccine that encodes the spike (S) protein, a coronavirus protective antigen. The effectiveness of the vaccine will be verified by using animal models.